FDA classifies recall of Boston Scientific catheters as ‘most serious’
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific’s catheters used in a type of minimally invasive surgery as “most serious”.
Related Articles
New Insight Into Long-Term Memory Formation During Deep Sleep | Docwire News
Intact human brain tissue was used by the researchers.
Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis
This clinical trial compares the efficacy of continuous vs intermittent infusion of a β-lactam antibiotic (piperacillin-tazobactam or meropenem) in decreasing all-cause mortality at 90 days…
Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care
This prospective study evaluates a clinically available Alzheimer disease blood test in primary and secondary care using predefined biomarker cutoff values.
International Consensus Criteria for Pediatric Sepsis and Septic Shock
This article revises criteria to identify sepsis in children after an exhaustive process that involved surveying clinicians, reviewing health record databases, conducting a systematic review…
FDA Receives sNDA for Roflumilast Cream Treatment of Children with Atopic Dermatitis
The submission of roflumilast’s supplemental New Drug Application to the FDA by Arcutis follows the conclusion of the INTEGUMENT-PED and INTEGUMENT-OLE studies.
Nokia Partners with Fraunhofer HHI & Charité for Sub-THz Wireless Medical Sensing
Nokia announced that it has launched a research initiative with Fraunhofer Heinrich Hertz Institute (HHI) and Charité – Universitätsmedizin Berlin to investigate the use of…
Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis
During 2000–20, NHS coverage of new drugs displaced more population health than it generated. Our results highlight the inherent trade-offs between individuals who directly benefit…
France says bird flu-free after month without outbreaks
France has declared itself to be free of highly pathogenic avian influenza in the absence of new outbreaks for more than a month, though the…
Could Paying for Obesity Medications Offset Obesity Care Costs?
With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will decrease obesity costs.
Unveiling adipose populations linked to metabolic health in obesity
Metabolic disease risk in individuals with obesity is variable and influenced by so-far-unknown factors. Reinisch and Ghosh et al. uncovered distinct cell populations and transcriptional programs…